Results 201 to 210 of about 483,678 (300)

Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection. [PDF]

Front Cell Infect Microbiol
Wang C, Yu M, Che Y, Du R, Xu Y, Niu J, Chi X.   +6 more
europepmc   +1 more source

Global patterns and trends in kidney cancer incidence and mortality

International Journal of Cancer, EarlyView.
What's New? Decreasing mortality from kidney cancer in developed countries contrasts with persistently high or rising mortality in less‐developed regions. Factors underlying this widening gap remain incompletely understood. Using GLOBOCAN 2022 data, the present study examined patterns in kidney cancer incidence and mortality worldwide and the relation ...
Anton Barchuk, Jerome Vignat, Kari A. O. Tikkinen, Ahmedin Jemal, Freddie Bray, Ariana Znaor   +5 more
wiley   +1 more source

Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals. [PDF]

Virol J
Aluora PO.
europepmc   +1 more source

Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine [PDF]

, 1991
Fung, J, Gavaler, JS, Starzl, TE, Van Thiel, DH, Wright, HI   +4 more
core  

Longitudinal changes in health‐related quality of life after a breast cancer diagnosis in sub‐Saharan Africa: Evidence from the prospective ABC‐DO cohort

International Journal of Cancer, EarlyView.
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed, Moses Galukande, Allen Naamala, Groesbeck Parham, Leeya Pinder, Angelica Anele, Shadrach Awa Offiah, Annelle Zietsman, Joachim Schüz, Valerie McCormack, Isabel dos‐Santos‐Silva   +10 more
wiley   +1 more source

Prevalence of viral hepatitis A and C in patients with inflammatory bowel disease: a nationwide population-based study in South Korea. [PDF]

Korean J Intern Med
Park JH, Park SH, Lee SP, Lee KN, Lee HL, Lee OY, Ryu S, Go J.   +7 more
europepmc   +1 more source

Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status

International Journal of Cancer, EarlyView.
What's New? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt, Sami Kilpinen, Johanna Arola, Benjamin Z. Sundqvist, Tom Böhling, Leif C. Andersson, Harri Sihto   +6 more
wiley   +1 more source

Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study. [PDF]

J Glob Health
Pascucci D, Nicolàs A, Taha A, Lazarus JV, Di Pumpo M, Tricomi V, Di Berardino F, La Vecchia C, Perez-Molina JA, Colucci G, Picchio CA, Pezzullo AM, Boccia S.   +12 more
europepmc   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

International Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott, Emma J. West, Rebecca J. Brownlie, Fay Ismail, Christy Ralph, Thomas Heineman, Matt Coffey, Alan A. Melcher, Alison Taylor, Salvatore Papa, Adel Samson   +10 more
wiley   +1 more source